FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ* Glucose Monitoring Technology
* glucose dehydrogenase pyrroloquinoline quinone
Date: August 13, 2009
Dear Healthcare Practitioner:
This is to alert you to the possibility of falsely elevated blood glucose results when using GDH-PQQ glucose test strips on patients who are receiving therapeutic products containing certain non-glucose sugars. These sugars can falsely elevate glucose results, which may mask significant hypoglycemia or prompt excessive insulin administration, leading to serious injury or death. The following provides background information on this problem, a summary of fatality reports FDA has received, and recommendations to reduce the risk. This problem can occur wherever these products are used including in-patient and out-patient healthcare facilities, and at home.
13.8.09
FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ* Glucose Monitoring Technology
via fda.gov
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment